CONSULTING AGREEMENTConsulting Agreement • May 29th, 2020 • Ziopharm Oncology Inc • Pharmaceutical preparations • Massachusetts
THIS CONSULTING AGREEMENT (the “Agreement”), made this 26th day of May, 2020 (the “Separation Date”), is entered into by Ziopharm Oncology, Inc., a Delaware corporation (the “Company”), and David Mauney, M.D. (the “Consultant”).
Separation Agreement and ReleaseSeparation Agreement and Release • May 29th, 2020 • Ziopharm Oncology Inc • Pharmaceutical preparations
This Separation Agreement and Release (“Agreement”) is made by and between David Mauney, M.D. (“Executive”) and Ziopharm Oncology, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Employment Agreement (as defined below).
